Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with -positive acute lymphoblastic leukemia.
作者信息
Frech Miriam, Jehn Lutz B, Stabla Kathleen, Mielke Stephan, Steffen Björn, Einsele Hermann, Metzelder Stephan K, Neubauer Andreas
机构信息
Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany.
Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Straβe 6, Germany.
出版信息
Haematologica. 2017 Apr;102(4):e160-e162. doi: 10.3324/haematol.2016.160531. Epub 2017 Jan 5.
Abstract
摘要
相似文献
1
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with -positive acute lymphoblastic leukemia.达沙替尼和异基因干细胞移植使一名老年B细胞阳性急性淋巴细胞白血病患者获得持续缓解。
Haematologica. 2017 Apr;102(4):e160-e162. doi: 10.3324/haematol.2016.160531. Epub 2017 Jan 5.
2
RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.RCSD1-ABL1 阳性 B 淋巴母细胞白血病对地塞米松和酪氨酸激酶抑制剂敏感，并通过染色体易位迅速克隆进化。
Int J Hematol. 2011 Sep;94(3):255-260. doi: 10.1007/s12185-011-0910-z. Epub 2011 Aug 24.
3
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.与RCSD1-ABL1新型融合基因相关的急性淋巴细胞白血病具有与BCR-ABL1融合不同的基因表达谱。
Leukemia. 2013 Jun;27(6):1422-4. doi: 10.1038/leu.2012.332. Epub 2012 Nov 20.
4
t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.1号染色体与9号染色体易位（1；9）（p34；q34）/SFPQ-ABL1融合见于1例Ph样普通B细胞急性淋巴细胞白血病患者。
Acta Haematol. 2017;137(1):40-43. doi: 10.1159/000452265. Epub 2016 Nov 29.
5
SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.含SNX2-ABL1的急性淋巴细胞白血病预后可能较差。
Leuk Lymphoma. 2017 Sep;58(9):1-3. doi: 10.1080/10428194.2017.1287357. Epub 2017 Feb 9.
6
Thinking outside of ABL1 for resistance to tyrosine kinase inhibitors: a perspective of the SEPT9-ABL1 fusion protein.跳出ABL1思考酪氨酸激酶抑制剂耐药性：SEPT9-ABL1融合蛋白的视角
Leuk Res. 2014 Dec;38(12):1399-400. doi: 10.1016/j.leukres.2014.09.015. Epub 2014 Oct 16.
7
Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation.达沙替尼治疗的异基因造血干细胞移植后复发的费城染色体阳性急性淋巴细胞白血病患者中出现大颗粒淋巴细胞扩增的患者特征。
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):e47-54. doi: 10.1016/j.clml.2014.09.006. Epub 2014 Sep 28.
8
A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.一种与t(1;9)(q24;q34)相关的B细胞急性淋巴细胞白血病中与ABL1融合的新伙伴基因。
Leukemia. 2007 Oct;21(10):2220-1. doi: 10.1038/sj.leu.2404773. Epub 2007 May 31.
9
Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.伊马替尼诱导复发的RCSD1-ABL1阳性急性淋巴细胞白血病长期缓解。
Haematologica. 2016 Aug;101(8):e332-5. doi: 10.3324/haematol.2015.139568. Epub 2016 Apr 28.
10
Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with .异基因移植后单药达沙替尼治疗伴……的B细胞急性淋巴细胞白血病的反应
Leuk Lymphoma. 2019 Nov;60(11):2832-2834. doi: 10.1080/10428194.2019.1605510. Epub 2019 Apr 24.
引用本文的文献
1
Imatinib and CAR T cell therapy enable sustained response in a young patient with refractory RCSD1-ABL1-positive acute lymphoblastic leukemia.伊马替尼和嵌合抗原受体T细胞疗法使一名患有难治性RCSD1-ABL1阳性急性淋巴细胞白血病的年轻患者获得持续缓解。
Ann Hematol. 2024 Jan;103(1):361-362. doi: 10.1007/s00277-023-05489-8. Epub 2023 Oct 21.
2
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in Class Rearrangements.费城样遗传学重排的成人 B 细胞 ALL：对化疗的耐药性和对 Class 重排的酪氨酸激酶抑制剂的反应。
JCO Precis Oncol. 2023 May;7:e2200707. doi: 10.1200/PO.22.00707.
3
Identification of IL10RA by Weighted Correlation Network Analysis and Validation of Its Association With Prognosis of Metastatic Melanoma.通过加权相关网络分析鉴定白细胞介素10受体A及其与转移性黑色素瘤预后相关性的验证
Front Cell Dev Biol. 2021 Jan 8;8:630790. doi: 10.3389/fcell.2020.630790. eCollection 2020.
4
A novel methylation signature predicts radiotherapy sensitivity in glioma.一种新型甲基化特征可预测脑胶质瘤的放疗敏感性。
Sci Rep. 2020 Nov 23;10(1):20406. doi: 10.1038/s41598-020-77259-9.
5
New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.治疗青少年 ALL 中具有挑战性亚型的新方法。
Curr Hematol Malig Rep. 2020 Dec;15(6):424-435. doi: 10.1007/s11899-020-00597-y.
6
How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia.我如何诊断和治疗费城染色体样急性淋巴细胞白血病。
Haematologica. 2019 Nov;104(11):2135-2143. doi: 10.3324/haematol.2018.207506. Epub 2019 Oct 3.
7
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.通过下一代测序进行急性髓细胞白血病的综合基因诊断。
Haematologica. 2019 Feb;104(2):277-287. doi: 10.3324/haematol.2018.194258. Epub 2018 Sep 6.
本文引用的文献
1
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病的管理
Leuk Suppl. 2012 Aug;1(Suppl 2):S7-9. doi: 10.1038/leusup.2012.7. Epub 2012 Aug 9.
2
Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.伊马替尼诱导复发的RCSD1-ABL1阳性急性淋巴细胞白血病长期缓解。
Haematologica. 2016 Aug;101(8):e332-5. doi: 10.3324/haematol.2015.139568. Epub 2016 Apr 28.
3
Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.药物反应谱分析可预测一名患有t(1;9)(q24;q34)相关B细胞急性淋巴细胞白血病的患者对波纳替尼的反应。
Blood Cancer J. 2015 Mar 13;5(3):e292. doi: 10.1038/bcj.2015.13.
4
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Ph 样急性淋巴细胞白血病中可靶向的激酶激活病变。
N Engl J Med. 2014 Sep 11;371(11):1005-15. doi: 10.1056/NEJMoa1403088.
5
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.与RCSD1-ABL1新型融合基因相关的急性淋巴细胞白血病具有与BCR-ABL1融合不同的基因表达谱。
Leukemia. 2013 Jun;27(6):1422-4. doi: 10.1038/leu.2012.332. Epub 2012 Nov 20.
6
RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.RCSD1-ABL1 阳性 B 淋巴母细胞白血病对地塞米松和酪氨酸激酶抑制剂敏感，并通过染色体易位迅速克隆进化。
Int J Hematol. 2011 Sep;94(3):255-260. doi: 10.1007/s12185-011-0910-z. Epub 2011 Aug 24.
7
Chromosomal translocation t(1;9)(q24;q34) in acute lymphoblastic leukemia patient involving the ABL1 gene.急性淋巴细胞白血病患者中涉及ABL1基因的染色体易位t(1;9)(q24;q34) 。
Leuk Res. 2011 Sep;35(9):e149-50. doi: 10.1016/j.leukres.2011.05.008.
8
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.针对化疗耐药的 B 系急性淋巴细胞白血病患者微小残留病灶的 T 细胞结合抗体blinatumomab 的靶向治疗可带来高缓解率和延长无白血病生存。
J Clin Oncol. 2011 Jun 20;29(18):2493-8. doi: 10.1200/JCO.2010.32.7270. Epub 2011 May 16.
9
ABL1 fusion genes in hematological malignancies: a review.血液恶性肿瘤中的 ABL1 融合基因：综述。
Eur J Haematol. 2011 May;86(5):361-71. doi: 10.1111/j.1600-0609.2011.01586.x. Epub 2011 Mar 23.
10
The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.使ABL1与一种前体mRNA加工基因SFPQ融合的t(1;9)(p34;q34)在急性淋巴细胞白血病中反复出现。
Leuk Res. 2011 Jul;35(7):e114-7. doi: 10.1016/j.leukres.2011.02.011. Epub 2011 Mar 9.
Zotero 插件